# REGULATORY SUPPORT FOR LEAD GENE THERAPY CANDIDATES AS A TREATMENT FOR ORGANIC ACIDEMIAS, PROPIONIC ACIDEMIA (PA) AND METHYLMALONIC ACIDEMIA TYPE B (MMAB)

> **NIH NIH N02** · — · 2024 · $46,977

## Abstract

The scope of this task order is for the regulatory strategy, planning, preparation, submission and maintenance of meeting requests and application packages (such as INTERACT meeting, pre-IND meeting, IND submission and maintenance) to the FDA to support the lead candidates
for gene therapy treatments.

## Key facts

- **NIH application ID:** 11088092
- **Project number:** 75N95022D00014-P00002-759502200001-1
- **Recipient organization:** —
- **Principal Investigator:** —
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $46,977
- **Award type:** —
- **Project period:** 2022-09-22 → 2025-09-21

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11088092

## Citation

> US National Institutes of Health, RePORTER application 11088092, REGULATORY SUPPORT FOR LEAD GENE THERAPY CANDIDATES AS A TREATMENT FOR ORGANIC ACIDEMIAS, PROPIONIC ACIDEMIA (PA) AND METHYLMALONIC ACIDEMIA TYPE B (MMAB) (75N95022D00014-P00002-759502200001-1). Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/grant/nih/11088092. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*